Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Report

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68038-438-3
  • Number of Report Pages: 175
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the healthcare contract development and manufacturing organization market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for healthcare contract development and manufacturing organization market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of healthcare contract development and manufacturing organization market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Healthcare Contract Development And Manufacturing Organization Market Categorization:

The healthcare contract development and manufacturing organization market was categorized into two segments, namely services (Contract Development, Contract Manufacturing), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The healthcare contract development and manufacturing organization market was segmented into services, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The healthcare contract development and manufacturing organization market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into thirty-two countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Netherlands; Belgium; Denmark; Sweden; Norway; China; India; Japan; Australia; Thailand; South Korea; Malaysia; New Zealand; Singapore; Philippines; Brazil; Mexico; Argentina; Colombia; Chile; South Africa, Saudi Arabia; UAE; Kuwait; Israel.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Healthcare contract development and manufacturing organization market companies & financials:

The healthcare contract development and manufacturing organization market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Catalent, Inc. - Catalent, Inc. is the prominent provider of advanced delivery technologies, development, and manufacturing solutions for biologics, drugs, gene therapies, and consumer health products. The company operates through four reportable segments: clinical supply service, oral drug delivery, biologics & specialty drug delivery, and Softgel Technologies. The company produces ~73 billion doses for around 7,000 customer products. It has development centers, manufacturing facilities, and sales offices around the world with over 39 operating facilities on five continents. The company has presence in North America, Latin America, Europe, and Asia Pacific regions.

  • Lonza Group Ltd. - Lonza is an international leader in life sciences with world-class manufacturing and process excellence. It is a preferred global partner for the biotech, pharmaceutical, and specialty ingredients markets. The pharma & biotech segment includes CDMO services for small molecules, mammalian & microbial, cell & gene technologies, and live biotherapeutics products and product businesses that comprise capsules & health ingredients. The specialty ingredients segment comprises microbial control solutions and specialty chemical services. The company offers a broad range of microbial control solutions that help create and maintain a healthy environment. It has more than 55 manufacturing sites and services around 30 countries in the world. It has a geographical footprint in the U.S., Europe, Asia Pacific, and Africa.

  • Recipharm AB - Recipharm AB offers a range of services across two different operating areas including development & technology that offers pharmaceutical development services and have four centers of excellence focused on drug substances, oral solids, inhalation, and analytical services; and the manufacturing services that comprise of two segments- sterile & inhalation, and solid & others. The services cover the whole life cycle of a pharmaceutical product from drug substance to commercial manufacturing. The company has over 30 development & manufacturing facilities in Europe, North America, Israel, and India.

  • Siegfried Holding AG - It is an internationally recognized outsourcing partner that provides custom services to its customers. The company provides pharmaceutical industry partners with a complete variety of services from the development of drug substances & drug products, registration, manufacturing, packaging, as well as logistics. The company also provides technology capabilities and services. The technology capability includes chemistry capabilities, analytical services, formulation technologies for drug products, continuous flow technology, and physical operations including micronization, million, and spray drying. The company provides services such as project management, regulatory affairs, supply chain management, and intellectual property. Its production facilities are located in the U.S., Germany, China, Malta, France, and Switzerland. The company is listed on the Swiss Stock Exchange in Zurich.

  • Patheon (Thermo Fisher Scientific Inc.) - Patheon is a CDMO that offers contract development & manufacturing services for biotechnology and pharmaceutical companies. Patheon and Fisher Clinical Services entered into a strategic agreement to offer pharmaceutical services solutions for the development of drug, clinical trial logistics, as well as commercial manufacturing. The company provides integrated end-to-end capabilities across all phases of development including API, biologics, formulation, logistics, clinical trial solutions, and commercial manufacturing. The company has served more than 400 clients and has manufacturing facilities in North America, Europe, Asia, and Australia.

  • Covance, Inc. - Covance, Inc. is a contract research organization that provides clinical and commercialization services to biopharmaceutical & pharmaceutical industries. The company is owned by LabCorp and provides services in more than 60 countries. It offers a wide range of drug development solutions to pharmaceutical industries and laboratory testing services to chemical industries. It is a key player in discovery, toxicology, & central laboratory services and one of the top companies that provides management services for phase III clinical trials to pharmaceutical industries.

  • Jabil, Inc. - Jabil, Inc. is a manufacturing solutions provider that provides comprehensive design, manufacturing, supply chain & product management services. Its manufacturing & supply chain management services & solutions comprise innovation, design, fabrication, assembly along with delivery & managing the product flow and resources. The company caters to segments such as diversified manufacturing services and electronic manufacturing services. Its services include electronics design, product management, and production management. It provides component selection, integrated design & engineering, supply chain services, automated assembly and others. The company’s products and services serve automotive, consumer lifestyle, wearable technologies, defense, aerospace, healthcare, emerging growth, healthcare, computing & storage, packaging, digital home, computing & storage, mobility, point of sale, printing, energy industries. The company had operations in facilities located around the world including countries such as the U.S., Singapore, Mexico, Malaysia, Hungary, and China.

  • Sanmina Corporation - Sanmina Corporation provides end-to-end design, manufacturing, & logistic solutions to OEMs mainly in medical, communication networks, multimedia, industrial & semiconductor, defense & aerospace, and computing & storage sectors. The company operates mainly in components, products & services, and integrated manufacturing solutions business segments. Its services include design & engineering, quick turn prototyping, test services, new product introduction, supply chain management, PCB assembly & SMT, and logistics. The company has geographic presence in nearly 25 countries across six continents.

  • IQVIA Holdings Inc. - IQVIA Holdings Inc., offers contract research services to medical device, biotechnology, and pharmaceutical companies. The service portfolio includes data analysis, regulatory assistance, patient recruitment, and laboratory testing. The company also offers technology, data, expertise, and analytics to various government agencies, healthcare payers, and medical researchers. The company operates in Americas, Asia Pacific, Africa, and Europe.

  • Flex Ltd. - Flex Ltd. is a well-known provider of Sketch-to-Scale services ranging from innovation, engineering, and manufacturing to supply chain services as well as solutions. The company, designs, develops, distributes, and manages entire packaged industrial & consumer products ranging from connected automotive systems & medical device to sustainable lightning and cloud & data solutions for various markets. The company operates in segments such as communications & electronics, consumer technologies, high-reliability solutions, and industrial & emerging industries. It provides services through a network of around 100 locations in ~35 countries across five continents. 

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Healthcare Contract Development And Manufacturing Organization Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Healthcare Contract Development And Manufacturing Organization Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon